77 results on '"CUI, Y. X."'
Search Results
52. Anti-HIV-1 Protease Triterpenoid Saponins from the Seeds of Aesculus chinensis
- Author
-
Yang, X.-W., Zhao, J., Cui, Y.-X., Liu, X.-H., Ma, C.-M., Hattori, M., and Zhang, L.-H.
- Abstract
Eight bioactive triterpenoid saponins (
1 −8 ) were isolated from the seeds of Aesculus chinensis, four of which are novel compounds. The major saponins were identified as escin Ia (1 ), Ib (2 ), isoescin Ia (3 ) and Ib (4 ), while the new compounds were identified as 22α-tigloyl-28-acetylprotoaescigenin-3β-O-[β-d -glucopyranosyl (1−2)] [β-d -glucopyranosyl (1−4)]-β-d -glucopyranosiduronic acid (escin IVc,5 ), 22α-angeloyl-28-acetylprotoaescigenin-3β-O-[β-d -glucopyranosyl (1−2)] [β-d -glucopyranosyl (1−4)]-β-d -glucopyranosiduronic acid (escin IVd,6 ), 28-tigloylprotoaescigenin-3β-O-[β-d -glucopyranosyl (1−2)] [β-d -glucopyranosyl (1−4)]-β-d -glucopyranosiduronic acid (escin IVe,7 ), and 28-angeloylprotoaescigenin-3β-O-[β-d -glucopyranosyl (1−2)] [β-d -glucopyranosyl (1−4)]-β-d -glucopyranosiduronic acid (escin IVf,8 ). The structures were determined by chemical and spectroscopic methods. All the above compounds were evaluated for their inhibitory activity against HIV-1 protease.- Published
- 1999
53. Impact fracture of rapid solidification processed Al-Li alloys
- Author
-
Zhen, L., Yang, D. Z., Yu, G. F., and Cui, Y. X.
- Published
- 1996
- Full Text
- View/download PDF
54. Interleukin 21 and its receptor play a role in proliferation, migration and invasion of breast cancer cells
- Author
-
Wang, L. -N, Cui, Y. -X, Ruge, F., and Wen G. Jiang
55. New roles of osteocytes in proliferation, migration and invasion of breast and prostate cancer cells
- Author
-
Cui, Y. -X, Evans, B. A. J., and Wen G. Jiang
56. Circulating microRNAs as potential biomarkers for unstable angina
- Author
-
Liu, J., Sufang Li, Lee, C. -Y, Song, J. -X, Zhang, F., Cui, Y. -X, and Chen, H.
57. MDM2 and PSMA Play Inhibitory Roles in Metastatic Breast Cancer Cells Through Regulation of Matrix Metalloproteinases
- Author
-
Bradbury, R., Wen G. Jiang, and Cui, Y. -X
58. ChemInform Abstract: Anodic Oxidation as a Synthetic Expedient to Naphthoquinone and Anthraquinone Ketals.
- Author
-
YANG, Z., CUI, Y. X., WONG, H. N. C., WANG, R. J., MAK, T. C. W., CHANG, H. M., and LEE, C. M.
- Published
- 1992
- Full Text
- View/download PDF
59. ChemInform Abstract: Facile Syntheses of Pseudo-α-D-glucopyranose and Pseudo-α- D-mannopyranose.
- Author
-
SHING, T. K. M., CUI, Y.-X., and TANG, Y.
- Published
- 1992
- Full Text
- View/download PDF
60. ChemInform Abstract: Naturally Occurring Benzofuran: Isolation, Structure Elucidation, and Total Synthesis of 5-(3-Hydroxypropyl)-7-methoxy-2-(3′-methoxy-4′- hydroxyphenyl)-3-benzo(b)furancarbaldehyde, a Novel Adenosine A1 Receptor Ligand Isolated from Salvia miltiorrhiza Bunge (Danshen).
- Author
-
YANG, Z., HON, P. M., CHUI, K. Y., XU, Z. L., CHANG, H. M., LEE, C. M., CUI, Y. X., WONG, H. N. C., POON, C. D., and FUNG, B. M.
- Published
- 1992
- Full Text
- View/download PDF
61. Measurement of the Cosmic Ray Helium Energy Spectrum from 70 GeV to 80 TeV with the DAMPE Space Mission
- Author
-
Fengtao Zhang, Y. F. Wang, Y. Y. Huang, Xiangpeng Guo, Jinfei Wu, D. Droz, J. N. Rao, Jinglai Duan, Yang Haibo, C. Liu, D. M. Wei, Zongye Zhang, X. Y. Ma, P. Azzarello, P. Fusco, Z. Y. Sun, Niu Xiaoyang, I. De Mitri, W. Zhang, Cihang Luo, C. Q. Feng, Yu Xing Cui, X. X. Li, M. S. Cai, Z.-Q. Shen, G. Marsella, X. L. Wang, S. Wang, F. Loparco, Guan Wen Yuan, Y. F. Wei, Jin Chang, Y. J. Zhang, Giacinto Donvito, W. X. Peng, J. L. Chen, Q. An, S. B. Liu, S. C. Wen, F. Gargano, Xiulian Pan, Y. Z. Gong, Cang Zhao, Yuqing Fan, T. S. Cui, H. T. Xu, A. De Benedittis, E. Catanzani, M. M. Salinas, Y. H. Yu, Zhao-Min Wang, Yun Long Zhang, Andrii Tykhonov, Wei Liu, Dingsong Wu, Zhenyu Zhang, Yifan Yang, G. F. Xue, Fang Fang, Pengtao Yang, M. Di Santo, R. Qiao, Yaohui Zhang, Xian Qiang Li, X. J. Bi, Chuan Yue, Min Gao, Z. Q. Xia, Shumei Wu, X. Y. Peng, M. M. Ma, Wenhan Jiang, J. Z. Wang, F. C. T. Barbato, M. Stolpovskiy, Hengchang Liu, F. Alemanno, P. Bernardini, J. J. Wei, Lihui Wu, Yujuan Liu, J. Liu, Yao Ming Liang, Z. Xu, A. Parenti, L. Feng, Yun-Zhi Zhang, A. Ruina, D. Mo, M. Y. Cui, Xin Wu, L. Silveri, Jun-jun Guo, Yu-Sa Wang, Hong Yun Zhao, W. Li, Hu-Rong Yao, Jinyuo Song, Z. Z. Xu, Z. X. Dong, Yan Fang Wang, Kun Fang, Y. Zhang, A. D'Amone, H. Su, Meng Su, A. Kotenko, Maria Ionica, Jie Kong, Shi-Jun Lei, Sheng Xia Zhang, Q. Yuan, Guangshun Huang, R. R. Fan, Peng-Xiong Ma, Xun Feng Zhao, Zhi Hui Xu, S.X. Li, A. Surdo, Yu-Xuan Zhu, X. J. Teng, Tie-Kuang Dong, W. H. Shen, Z. T. Shen, D. D'Urso, Zu-Cheng Chen, L. G. Wang, Dong Ya Guo, Xiaoyuan Huang, Y. M. Hu, F. de Palma, Hao Ting Dai, C. Perrina, Tianxiao Ma, Donghong Chen, Kai-Kai Duan, Maksym Deliyergiyev, D. Kyratzis, K. Gong, Chengrui Zhou, Mn Mazziotta, G. Z. Shang, Shuang Xue Han, J. J. Zang, Huaguang Wang, Alemanno F., An Q., Azzarello P., Barbato F.C.T., Bernardini P., Bi X.J., Cai M.S., Catanzani E., Chang J., Chen D.Y., Chen J.L., Chen Z.F., Cui M.Y., Cui T.S., Cui Y.X., Dai H.T., D'amone A., De Benedittis A., De Mitri I., De Palma F., Deliyergiyev M., Di Santo M., Dong T.K., Dong Z.X., Donvito G., Droz D., Duan J.L., Duan K.K., D'urso D., Fan R.R., Fan Y.Z., Fang K., Fang F., Feng C.Q., Feng L., Fusco P., Gao M., Gargano F., Gong K., Gong Y.Z., Guo D.Y., Guo J.H., Guo X.L., Han S.X., Hu Y.M., Huang G.S., Huang X.Y., Huang Y.Y., Ionica M., Jiang W., Kong J., Kotenko A., Kyratzis D., Lei S.J., Li S., Li W.L., Li X., Li X.Q., Liang Y.M., Liu C.M., Liu H., Liu J., Liu S.B., Liu W.Q., Liu Y., Loparco F., Luo C.N., Ma M., Ma P.X., Ma T., Ma X.Y., Marsella G., Mazziotta M.N., Mo D., Niu X.Y., Pan X., Parenti A., Peng W.X., Peng X.Y., Perrina C., Qiao R., Rao J.N., Ruina A., Salinas M.M., Shang G.Z., Shen W.H., Shen Z.Q., Shen Z.T., Silveri L., Song J.X., Stolpovskiy M., Su H., Su M., Sun Z.Y., Surdo A., Teng X.J., Tykhonov A., Wang H., Wang J.Z., Wang L.G., Wang S., Wang X.L., Wang Y., Wang Y.F., Wang Y.Z., Wang Z.M., Wei D.M., Wei J.J., Wei Y.F., Wen S.C., Wu D., Wu J., Wu L.B., Wu S.S., Wu X., Xia Z.Q., Xu H.T., Xu Z.H., Xu Z.L., Xu Z.Z., Xue G.F., Yang H.B., Yang P., Yang Y.Q., Yao H.J., Yu Y.H., Yuan G.W., Yuan Q., Yue C., Zang J.J., Zhang F., Zhang S.X., Zhang W.Z., Zhang Y., Zhang Y.J., Zhang Y.L., Zhang Y.P., Zhang Y.Q., Zhang Z., Zhang Z.Y., Zhao C., Zhao H.Y., Zhao X.F., Zhou C.Y., Zhu Y., Alemanno, F., An, Q., Azzarello, P., Barbato, F. C. T., Bernardini, P., Bi, X. J., Cai, M. S., Catanzani, E., Chang, J., Chen, D. Y., Chen, J. L., Chen, Z. F., Cui, M. Y., Cui, T. S., Cui, Y. X., Dai, H. T., D’Amone, A., De Benedittis, A., De Mitri, I., de Palma, F., Deliyergiyev, M., Di Santo, M., Dong, T. K., Dong, Z. X., Donvito, G., Droz, D., Duan, J. L., Duan, K. K., D’Urso, D., Fan, R. R., Fan, Y. Z., Fang, K., Fang, F., Feng, C. Q., Feng, L., Fusco, P., Gao, M., Gargano, F., Gong, K., Gong, Y. Z., Guo, D. Y., Guo, J. H., Guo, X. L., Han, S. X., Hu, Y. M., Huang, G. S., Huang, X. Y., Huang, Y. Y., Ionica, M., Jiang, W., Kong, J., Kotenko, A., Kyratzis, D., Lei, S. J., Li, S., Li, W. L., Li, X., Li, X. Q., Liang, Y. M., Liu, C. M., Liu, H., Liu, J., Liu, S. B., Liu, W. Q., Liu, Y., Loparco, F., Luo, C. N., Ma, M., Ma, P. X., Ma, T., Ma, X. Y., Marsella, G., Mazziotta, M. N., Mo, D., Niu, X. Y., Pan, X., Parenti, A., Peng, W. X., Peng, X. Y., Perrina, C., Qiao, R., Rao, J. N., Ruina, A., Salinas, M. M., Shang, G. Z., Shen, W. H., Shen, Z. Q., Shen, Z. T., Silveri, L., Song, J. X., Stolpovskiy, M., Su, H., Su, M., Sun, Z. Y., Surdo, A., Teng, X. J., Tykhonov, A., Wang, H., Wang, J. Z., Wang, L. G., Wang, S., Wang, X. L., Wang, Y., Wang, Y. F., Wang, Y. Z., Wang, Z. M., Wei, D. M., Wei, J. J., Wei, Y. F., Wen, S. C., Wu, D., Wu, J., Wu, L. B., Wu, S. S., Wu, X., Xia, Z. Q., Xu, H. T., Xu, Z. H., Xu, Z. L., Xu, Z. Z., Xue, G. F., Yang, H. B., Yang, P., Yang, Y. Q., Yao, H. J., Yu, Y. H., Yuan, G. W., Yuan, Q., Yue, C., Zang, J. J., Zhang, F., Zhang, S. X., Zhang, W. Z., Zhang, Y., Zhang, Y. J., Zhang, Y. L., Zhang, Y. P., Zhang, Y. Q., Zhang, Z., Zhang, Z. Y., Zhao, C., Zhao, H. Y., Zhao, X. F., Zhou, C. Y., and Zhu, Y.
- Subjects
Astrophysics::High Energy Astrophysical Phenomena ,Dark matter ,General Physics and Astronomy ,chemistry.chemical_element ,FOS: Physical sciences ,Cosmic ray ,Space (mathematics) ,01 natural sciences ,7. Clean energy ,Cosmic ray, helium ,High Energy Physics - Experiment ,Nuclear physics ,High Energy Physics - Experiment (hep-ex) ,0103 physical sciences ,Energy spectrum ,cosmic rays, dark matter, space ,crystals ,010306 general physics ,Helium ,Physics ,High Energy Astrophysical Phenomena (astro-ph.HE) ,COSMIC cancer database ,detector ,Settore FIS/01 - Fisica Sperimentale ,calibration ,chemistry ,Particle ,Astrophysics - High Energy Astrophysical Phenomena ,Nucleon ,performance - Abstract
The measurement of the energy spectrum of cosmic ray helium nuclei from 70 GeV to 80 TeV using 4.5 years of data recorded by the DArk Matter Particle Explorer (DAMPE) is reported in this work. A hardening of the spectrum is observed at an energy of about 1.3 TeV, similar to previous observations. In addition, a spectral softening at about 34 TeV is revealed for the first time with large statistics and well controlled systematic uncertainties, with an overall significance of $4.3\sigma$. The DAMPE spectral measurements of both cosmic protons and helium nuclei suggest a particle charge dependent softening energy, although with current uncertainties a dependence on the number of nucleons cannot be ruled out., Comment: 11 pages, 13 figures, published in Phys. Rev. Lett. Add one more digit for first three columns in Table S2
- Published
- 2021
62. [The diagnostic value of genetic testing in familial hypercholesterolemia in patients with premature myocardial infarction].
- Author
-
Cui YX, Song JX, Li ZY, Li SF, Liu CF, and Chen H
- Subjects
- Male, Humans, Adult, Middle Aged, Proprotein Convertase 9 genetics, Retrospective Studies, Cross-Sectional Studies, Genetic Testing, Mutation, Receptors, LDL genetics, Hyperlipoproteinemia Type II diagnosis, Hyperlipoproteinemia Type II genetics, Myocardial Infarction diagnosis, Myocardial Infarction genetics
- Abstract
Objective: To evaluate the diagnostic value of gene testing in familial hypercholesterolemia (FH) in patients with premature myocardial infarction(PMI). Methods: This study was a single center cross-sectional study. A retrospective analysis was made on PMI patients who visited the People's Hospital of Peking University from May 1, 2015 to March 31, 2017. Clinical data of patients was collected and gene testing of FH related genes low density lipoprotein receptor (LDLR), proprotein convertase subtilisin/kexin type 9 (PCSK9), apolipoprotein B(APOB) and low density lipoprotein receptor adaptor protein 1(LDLRAP1) was carried out. Clinical diagnosis of FH patients was performed using Simon Broome criteria, DLCN criteria, and FH Chinese expert consensus. Results: There were 188 males (83.6%) among 225 PMI patients, and the age of the first myocardial infarction was (46.6±7.2) years old. Ten patients carried FH pathogenic or possibly pathogenic mutations (4.4%). Compared with Simon Broome standard, DLCN standard and FH Chinese expert consensus, gene testing increased the diagnostic rate of FH by 53.3%, 33.3% and 42.1% respectively. Conclusion: Gene testing is helpful to improve the diagnosis of FH, and it is important to start the standard treatment of FH as early as possible in patients with premature myocardial infarction.
- Published
- 2024
- Full Text
- View/download PDF
63. [Rosuvastatin acts on the lymphatic system to improve atherosclerosis].
- Author
-
Song ZQ, Song JX, Cui YX, Li SF, and Chen H
- Subjects
- Rats, Mice, Animals, Rosuvastatin Calcium pharmacology, Rosuvastatin Calcium therapeutic use, Vascular Endothelial Growth Factor C, Endothelial Cells metabolism, Cholesterol, HDL, Lymphatic System metabolism, Atherosclerosis drug therapy, Plaque, Atherosclerotic
- Abstract
Objective: To investigate whether rosuvastatin acts on lymphatic system and influences lymphatic system-mediated reverse cholesterol transport to play an anti-atherosclerosis role. Methods: Forty-eight apolipoprotein E
-/- mice fed a high fat diet were used to construct the atherosclerosis model. They were randomly divided into 4 groups with 12 rats in each group. They were treated with rosuvastatin, vascular endothelial growth factor-C (VEGF-C) and rosuvastatin+VEGF-C inhibitors as experimental group, and no intervention measures were given in control group. After 8 weeks, aortic plaque area, high density lipoprotein cholesterol (HDL-C) content in lymph fluid, the function of popliteal lymphatic drainage of peripheral Evans blue, and the ability of lymphatic system to transport peripheral cell membrane red fluorescent probes to label high-density lipoprotein (HDL) were detected. Subsequently, the effects of rosuvastatin on proliferation, migration and tubular function of lymphoendothelial cells and the expression of scavenger receptor class B type 1 (SR-B1) on lymphoendothelial cells at different concentrations were detected. Results: Compared with the control group, Rosuvastatin and VEGF-C could reduce the area of aortic atherosclerotic plaque ( P <0.05). In addition to rosuvastatin plus VEGF-C inhibitor, the intra-aortic plaque area increased ( P <0.05). Compared with the control group, Rosuvastatin could increase the content of HDL-C in lymphatic fluid ( P <0.05), enhance the drainage function of lymphatic vessels, and enhance the capacity of HDL in the transport tissue fluid of lymphatic system. Compared with the control group, VEGF-C increased the content of HDL-C in mouse lymph fluid ( P< 0.01), enhanced the drainage function of popliteal lymphatic canal, and enhanced the ability of lymphatic system to transport HDL. With the addition of VEGF-C inhibitor on the basis of rosuvastatin, the content of HDL-C in lymph fluid was reduced, the drainage of popliteal lymphatic canal was interrupted, and the ability of lymphatic system to transport HDL was reduced. Western blotting showed that rosuvastatin increased the protein expression of SR-B1. Conclusion: Rosuvastatin can promote the proliferation, migration and tube formation of lymphatic endothelial cells. At the same time, SR-B1 expression on lymphatic endothelial cells is promoted, thus enhancing the lymphatic system mediated cholesterol reversal transport and playing the role of anti-atherosclerosis.- Published
- 2023
- Full Text
- View/download PDF
64. [A 10-year retrospective analysis of spectrums and treatment options of orthostatic intolerance and sitting intolerance in children].
- Author
-
Cui YX, DU JB, Zhang QY, Liao Y, Liu P, Wang YL, Qi JG, Yan H, Xu WR, Liu XQ, Sun Y, Sun CF, Zhang CY, Chen YH, and Jin HF
- Subjects
- Child, Female, Humans, Male, Electrolytes, Metoprolol, Retrospective Studies, Salts, Sitting Position, Tilt-Table Test, Midodrine, Orthostatic Intolerance diagnosis, Orthostatic Intolerance epidemiology, Orthostatic Intolerance therapy, Postural Orthostatic Tachycardia Syndrome diagnosis, Syncope, Vasovagal diagnosis
- Abstract
Objective: To analyze the disease spectrums underlying orthostatic intolerance (OI) and sitting intolerance (SI) in Chinese children, and to understand the clinical empirical treatment options., Methods: The medical records including history, physical examination, laboratory examination, and imagological examination of children were retrospectively studied in Peking University First Hospital from 2012 to 2021. All the children who met the diagnostic criteria of OI and SI were enrolled in the study. The disease spectrums underlying OI and SI and treatment options during the last 10 years were analyzed., Results: A total of 2 110 cases of OI and SI patients were collected in the last 10 years, including 943 males (44.69%) and 1 167 females (55.31%) aged 4-18 years, with an average of (11.34±2.84) years. The overall case number was in an increasing trend over the year. In the OI spectrum, postural tachycardia syndrome (POTS) accounted for 826 cases (39.15%), followed by vasovagal syncope (VVS) (634 cases, 30.05%). The highest proportion of SI spectrum was sitting tachycardia (STS) (8 cases, 0.38%), followed by sitting hypertension (SHT) (2 cases, 0.09%). The most common comorbidity of OI and SI was POTS coexisting with STS (36 cases, 1.71%). The highest proportion of treatment options was autonomic nerve function exercise (757 cases, 35.88%), followed by oral rehydration salts (ORS) (687 cases, 32.56%), metoprolol (307 cases, 14.55%), midodrine (142 cases, 6.73%), ORS plus metoprolol (138 cases, 6.54%), and ORS plus midodrine (79 cases, 3.74%). The patients with POTS coexisting with VVS were more likely to receive pharmacological intervention than the patients with POTS and the patients with VVS (41.95% vs. 30.51% vs . 28.08%, χ
2 = 20.319, P < 0.01), but there was no significant difference in the proportion of treatment options between the patients with POTS and the patients with VVS., Conclusion: POTS and VVS in children are the main underlying diseases of OI, while SI is a new disease discovered recently. The number of children with OI and SI showed an increasing trend. The main treatment methods are autonomic nerve function exercise and ORS. Children with VVS coexisting with POTS were more likely to take pharmacological treatments than those with VVS or POTS only.- Published
- 2022
65. [The influence of cachexia on the immunotherapy efficacy of Sintilimab for non-small cell lung cancer].
- Author
-
Li XQ, Zhao ZL, Hou ML, Cui YX, Han SY, and Fu FF
- Subjects
- Antibodies, Monoclonal, Humanized, Cachexia etiology, Humans, Immunotherapy, Retrospective Studies, Carcinoma, Non-Small-Cell Lung complications, Carcinoma, Non-Small-Cell Lung drug therapy, Lung Neoplasms complications, Lung Neoplasms drug therapy
- Abstract
Objective: To investigate whether cachexia affects the treatment effect of immune checkpoint inhibitors for non-small cell lung cancer (NSCLC). Methods: The prognosis of 62 patients with advanced NSCLC who received anti-programmed cell death-1 (PD-1) in Henan Provincial People's Hospital from 2019 to 2021 were retrospectively analyzed. The cachexia was evaluated before and after the second course of immunotherapy. Kaplan-Meier and Log rank methods were used for survival analysis, Cox regression model was used for multivariate analysis, and Spearman's correlation analysis was used for correlation analysis. Results: After the second course of immunotherapy, psoas major muscle area (PMMA) values of the cachexia group and the control group were (14.10±4.09) and (11.66±3.22) cm(2) respectively, with statistics significance ( P =0.001). The level of Prealbumin and body weight were correlated with cachexia ( P <0.05). The 6-month and 1-year survival rates of 62 cases in the whole group were 58.6% and 42.5%, respectively. The progression-free survival (PFS) in the control group (7.6 months) was higher than that in the cachexia group (3.8 months, P =0.006). The PFS in patients with high expression of PD-L1 (7.1 months) was longer than that of patients with low expression (3.8 months, P =0.009). The overall survival (OS) in the cachexia group (6.3 months) was lower than that in the control group (18.2 months, P =0.006). The OS in patients with high expression of PD-L1 (14.5 months) was longer than that of patients with low expression (1 months, P =0.038). The level of Prealbumin, the level of PD-L1 expression and the change rate of PMMA were related to the OS of the patients ( P <0.05). The level of Prealbumin and the change rate of PMMA were the independent influencing factors of the OS ( P <0.05). The PMMA and the level of Prealbumin were negatively correlated ( r =-0.003 8, P <0.05). Conclusion: Cachexia has a negative impact on the outcomes of patients who received anti-PD-1 immune checkpoint inhibitor therapy.
- Published
- 2021
- Full Text
- View/download PDF
66. [Progress of researches on serine protease inhibitors for zoonotic cestode family Taeniidae].
- Author
-
Song WY, Wang XR, Yu MC, Cui YX, Qi Y, and Sun SM
- Subjects
- Animals, Serine Proteinase Inhibitors pharmacology, Zoonoses, Cestoda, Vaccines
- Abstract
Serine protease inhibitor, a protein superfamily that inhibits the serine protease activity, protects hosts from parasitic infections. This review describes the spatial structure and classification of serine protease inhibitor, mechanisms underlying the interplay between serine protease inhibitor and host immune responses and current advances in serine protease inhibitor of zoonotic cestode family Taeniidae, so as to provide insights into the diagnosis of zoonotic tapeworm infections, discovery of therapeutic targets and screening of vaccine candidates.
- Published
- 2021
- Full Text
- View/download PDF
67. Molecular mechanism concerning conformational changes of CDK2 mediated by binding of inhibitors using molecular dynamics simulations and principal component analysis.
- Author
-
Liang SS, Liu XG, Cui YX, Zhang SL, Zhang QG, and Chen JZ
- Abstract
Cyclin-dependent kinase 2 (CDK2) has been regarded as a promising drug target for anti-tumour agents. In this study, molecular dynamics (MD) simulations and principal component (PC) analysis were used to explore binding mechanism of three inhibitors 1PU, CDK, 50Z to CDK2 and influences of their bindings on conformational changes of CDK2. The results show that bindings of inhibitors yield obvious impacts on internal dynamics, movement patterns and conformational changes of CDK2. In addition, molecular mechanics generalized Born surface area (MM-GBSA) was applied to calculate binding free energies between three inhibitors and CDK2 and evaluate their binding ability to CDK2. The results show that CDK has the strongest binding to CDK2 among the current three inhibitors. Residue-based free energy decomposition method was further utilized to decode the contributions of a single residue to binding of inhibitors, and it was found that three inhibitors not only produce hydrogen bonding interactions and hydrophobic interactions with key residues of CDK2, which promotes binding of three inhibitors to CDK2, but also share similar binding modes. This work is expected to be helpful for design of efficient drugs targeting CDK2.
- Published
- 2021
- Full Text
- View/download PDF
68. [Analysis of pesticide poisoning in Ji'nan during 2012-2016].
- Author
-
Peng XM, Cui YX, Cui LL, and Zhou JW
- Subjects
- Aged, China epidemiology, Dichlorvos, Humans, Incidence, Poisoning mortality, Environmental Exposure, Herbicides poisoning, Paraquat poisoning, Pesticides poisoning, Poisoning epidemiology
- Abstract
Objective: To study the current situation and distribution characteristics of pesticide poisoning in Ji'nan area, and to provide the basis for formulating the policy of scientific prevention and control of pesticide poisoning. Methods: The cases of pesticide poisoning from 2012 to 2016 were collected from medical institutions in Ji'nan, and the data was subjected to statistical analysis. Results: From 2012 to 2016 in Ji'nan reported a total of 2 237 cases of pesticide poisoning, non productive pesticide poisoning cases (72.78%, 2 149/2 237) and mortality (17.73%, 381/2 149) was significantly higher than that of productive pesticide poisoning. The average age is 46.78±18.57. The highest mortality rate of pesticide poisoning is more than 70 age group of the non productive pesticide poisoning. Organophosphorus pesticides (67.68%, 1 514/2 237) are the main pesticides causing poisoning, followed by herbicide (23.74%, 531/2 237). The highest mortality rate of pesticide was Paraquat (36.45%, 160/439), the second is the dichlorvos (19.19%, 170/886). Conclusion: Pesticide poisoning is a public health problem and social problem which is harmful to the health of the residents in Ji'nan. It is necessary to strengthen the control and management of high toxic pesticides. Pay attention to the psychological intervention of elderly people to reduce the incidence of pesticide poisoning.
- Published
- 2018
- Full Text
- View/download PDF
69. Role of IL-8 rs4073 and rs2227306 polymorphisms in the development of primary gouty arthritis in a Chinese population.
- Author
-
Cui YX, Zhao H, and Guo HQ
- Subjects
- Female, Humans, Male, Middle Aged, Risk Factors, Arthritis, Gouty genetics, Asian People genetics, Genetic Predisposition to Disease, Interleukin-8 genetics, Polymorphism, Single Nucleotide genetics
- Abstract
In this study, we investigated the role of two single nucleotide polymorphisms in the promoter region of the interleukin-8 gene (IL-8; rs4073 and rs2227306) in the susceptibility to primary gouty arthritis in a Chinese population. Three hundred and twelve patients with primary gouty arthritis and 340 healthy controls were recruited from the Yan'an University Affiliated Hospital between January 2014 and March 2015. The IL-8 rs4073 and rs2227306 polymorphisms were genotyped by polymerase chain reaction combined with restriction fragment length polymorphism. Unconditional multiple-logistic regression analysis revealed that the TT genotype of rs4073 was correlated with primary gouty arthritis risk, compared to the AA genotype [adjusted odds ratio (OR) = 1.65, 95% confidence interval (CI) = 1.08-2.54; P = 0.02]. In addition, the IL-8 rs4073 T allele was associated with a significant elevated risk of primary gouty arthritis, in comparison to the A allele (OR = 1.34, 95%CI = 1.07-1.67; P = 0.01). However, we observed no significant relationship between the IL-8 rs2227306 polymorphism and primary gouty arthritis risk. The results of this study suggest that the IL-8 rs4073 polymorphism could be a marker for primary gouty arthritis development.
- Published
- 2016
- Full Text
- View/download PDF
70. [A meta-analysis of microRNA-149, microRNA-499 gene polymorphism and susceptibility to hepatocellular carcinoma].
- Author
-
Ye LX, Fu CW, Jiang F, Cui YX, and Meng W
- Subjects
- Alleles, Carcinoma, Hepatocellular ethnology, Case-Control Studies, China epidemiology, Genotype, Humans, Liver Neoplasms ethnology, Asian People genetics, Carcinoma, Hepatocellular genetics, Genetic Predisposition to Disease, Liver Neoplasms genetics, MicroRNAs genetics, Polymorphism, Single Nucleotide
- Abstract
Objective: To investigate the relationship between microRNA-149 (rs2292832), microRNA-499 (rs2292832) polymorphism and hepatocellular carcinoma susceptibility by meta-analysis., Methods: We used"hepatocellular carcinoma/HCC","miRNA-149/miR-149/microRNA-149", and"miRNA-499/miR-499/microRNA-499"as key words to search papers in databases including China National Knowledge Internet (CNKI), Chinese BioMedical Literature (CBM), Vip Citation Databases (VIP), Wanfang, PubMed and Web of Science databases, and collected the case-control studies on the association of rs2292832 or rs3746444 and the susceptibility to hepatocellular carcinoma from updated to May 31st 2015. Data were extracted by two independent reviewers and pooled OR with 95% CI was calculated. A bioinformatics analysis was further conducted., Results: A total of 13 research papers were collected, and 5 studies for rs2292832 and 12 studies for rs3746444. 1 096 cases and 1 701 controls were included for rs2292832 and 3 117 cases and 4 126 controls were included for rs3746444. Meta-analysis failed to detect associations between rs2292832, rs3746444 and susceptibility to hepatocellular carcinoma under each genetic model tested and alleles of OR(95% CI) were 0.99(0.78-1.28) and 1.11(0.88-1.40). However, subgroup analysis showed that rs3746444 C allele seem to be associated with an increased hepatocellular carcinoma risk in both researches which had more than 400 samples and which used more accurate genotyping methods, and OR(95%CI) were 1.32(1.02-1.70) and 1.34(1.09-1.66), respectively. Furthermore, bioinformatics analysis also showed that the expression of both SNPs were down-regulated in HepG2 cells and indicated possible functional effects on gene transcription. Cochran's Q test indicated that there was the heterogeneity among the studies included., Conclusions: No significant association was found between rs2292832, rs3746444 and susceptibility to hepatocellular carcinoma, but subgroup study indicated C allele might be associated with increased hepatocellular carcinoma risk for rs3746444. Bioinformatics analysis indicated that the two SNPs might have possible influence on gene transcription.
- Published
- 2016
- Full Text
- View/download PDF
71. A novel nonsense mutation in the sedlin gene (SEDL) causes severe spondyloepiphyseal dysplasia tarda in a five-generation Chinese pedigree.
- Author
-
Xia XY, Yu J, Li WW, Li N, Wu QY, Zhou X, Cui YX, and Li XJ
- Subjects
- Adult, Female, High-Throughput Nucleotide Sequencing, Humans, Male, Middle Aged, Osteochondrodysplasias pathology, Codon, Nonsense genetics, Membrane Transport Proteins genetics, Osteochondrodysplasias genetics, Transcription Factors genetics
- Abstract
Spondyloepiphyseal dysplasia tarda (SEDT) is an X-linked recessive osteochondrodysplasia characterized by disproportionately short stature and degenerative joint disease. The objective of this study was to describe a novel nonsense mutation in the sedlin gene (SEDL) causing severe SEDT in a large Chinese pedigree. The clinical features of all affected individuals and female carriers were presented. Four affected males of the family were diagnosed with SEDT according to their clinical and radiological features. Direct DNA sequencing of SEDL was performed. Reverse-transcription polymerase chain reaction (RT-PCR) experiments of total RNA from blood lymphocytes were performed to confirm the defect in SEDL. DNA sequencing revealed that all of the affected males carried a nonsense mutation (c.61G>T) in SEDL that has not been previously reported. The c.61G>T mutation resulted in a premature translation termination codon (GAG>TAG) at amino acid position 21 (p.E21*), and was predicted to initiate the degradation of mutant transcripts through the nonsense-mediated mRNA decay pathway. Two female carriers showed typical sequencing chromatograms of a heterozygote. Following genetic counseling, individual IV7 gave birth to a healthy baby. Therefore, identification of the novel nonsense mutation (c.61G>T) in the SEDT family enables carrier detection, genetic counseling, and prenatal diagnosis. The detailed genotype/phenotype descriptions contribute to the SEDL mutation spectrum. The continued identification of mutations in SEDT patients will greatly aid further elucidation of the role of the sedlin protein in normal bone growth.
- Published
- 2014
- Full Text
- View/download PDF
72. Determining polarity and dislocation core structures at atomic level for epitaxial AlN/(0001)6H-SiC from a single image in HRTEM.
- Author
-
Cui YX, Wang YM, Wen C, Ge BH, Li FH, Chen Y, and Chen H
- Abstract
The polarity of epitaxial AlN film grown on (0001)6H-SiC and dislocation core structures in the film have been studied using a 200 kV LaB6 high-resolution transmission electron microscope of point resolution about 0.2 nm. A posterior image processing technique, the image deconvolution, was utilized to transform a single [21¯1¯0] image that does not intuitively represent the structure into the projected structure map. The adjacent Al and N projected atomic columns with the interatomic distance 0.109 nm can be distinguished from each other by analyzing the image contrast change with the sample thickness based on the pseudo-weak phase object approximation. This makes possible to derive the polarity and core structures of partial dislocations in the epitaxial AlN film at atomic level from a single image without relying on any other additional structure information. The atomic configurations for two partial dislocations containing a 10-atom ring and a 12-atom ring, respectively, have been attained. The method is available for II-VI and other III-V compounds. Its principle and procedure are briefly introduced., (Copyright © 2012 Elsevier B.V. All rights reserved.)
- Published
- 2013
- Full Text
- View/download PDF
73. Beneficial effect of recombinant human growth hormone on the intestinal mucosa barrier of septic rats.
- Author
-
Yi C, Cao Y, Wang SR, Xu YZ, Huang H, Cui YX, and Huang Y
- Subjects
- Abdomen, Animals, Biomarkers analysis, Escherichia coli Infections physiopathology, Female, Humans, Insulin-Like Growth Factor I analysis, RNA, Messenger analysis, Rats, Rats, Sprague-Dawley, Recombinant Proteins therapeutic use, Shock, Septic physiopathology, bcl-2-Associated X Protein analysis, Bacterial Translocation drug effects, Escherichia coli Infections drug therapy, Human Growth Hormone therapeutic use, Intestinal Mucosa drug effects, Shock, Septic drug therapy
- Abstract
The objective of the present study was to investigate the effects of recombinant human growth hormone (rhGH) on the intestinal mucosa barrier of septic rats and explore its possible mechanism. Female Sprague-Dawley rats were randomized into three groups: control, Escherichia coli-induced sepsis (S) and treatment (T) groups. Groups S and T were subdivided into subgroups 1d and 3d, respectively. Expression of liver insulin-like growth factor-1 (IGF-1) mRNA, Bcl-2 and Bax protein levels and the intestinal Bax/Bcl-2 ratio, and plasma GH and IGF-1 levels were determined. Histological examination of the intestine was performed and bacterial translocation was determined. rhGH significantly attenuated intestinal mucosal injuries and bacterial translocation in septic rats, markedly decreased Bax protein levels, inhibited the decrease of Bcl-2 protein expression and maintained the Bax/Bcl-2 ratio in the intestine. rhGH given after sepsis significantly improved levels of plasma GH (T1d: 1.28 +/- 0.24; T3d: 2.14 +/- 0.48 microg/L vs S1d: 0.74 +/- 0.12; S3d: 0.60 +/- 0.18 microg/L; P < 0.05) and IGF-1 (T1d: 168.94 +/- 65.67; T3d: 201.56 +/- 64.98 microg/L vs S1d: 116.72 +/- 13.96; S3d: 107.50 +/- 23.53 microg/L; P < 0.05) and expression of liver IGF-1 mRNA (T1d: 0.98 +/- 0.20; T3d: 1.76 +/- 0.17 vs S1d: 0.38 +/- 0.09; S3d: 0.46 +/- 0.10; P < 0.05). These findings indicate that treatment with rhGH had beneficial effects on the maintenance of the integrity of the intestinal mucosa barrier in septic rats.
- Published
- 2007
- Full Text
- View/download PDF
74. [Studies on flavonoids from leave of Eucommia ulmoides Oliv].
- Author
-
Cheng J, Zhao YY, Cui YX, and Cheng TM
- Subjects
- Alkaloids chemistry, Alkaloids isolation & purification, Flavonoids chemistry, Plant Leaves chemistry, Rutin chemistry, Rutin isolation & purification, Eucommiaceae chemistry, Flavonoids isolation & purification, Kaempferols, Plants, Medicinal chemistry
- Abstract
Objective: To separate the constituents from Eucommia ulmoides., Method: The constituents were separated by the repeated chromatography and identified by spectral methods., Result: The seven compounds were obtained, which were kaempferol(1), quercetin(2), astragalin(3), hirsutin(4), rutin(5), 3,4-dihydrobenzonic acid(6), ethyl glucopyranoside(7)., Conclusion: Compounds 3-7 were obtained from leaves of E. ulmoides for the first time.
- Published
- 2000
75. [Studies on chemical constituents of Stelmatocrypton khasianum (Benth.) H. Bail].
- Author
-
Zhang QY, Zhao YY, Liu XH, Zhang NX, Cui YX, and Cheng TM
- Subjects
- Benzaldehydes chemistry, Benzaldehydes isolation & purification, Coumarins, Dioxanes chemistry, Molecular Structure, Apocynaceae chemistry, Dioxanes isolation & purification, Plants, Medicinal chemistry
- Abstract
Objective: To study the chemical constituents of Stelmatocrypton khasinum., Method: Using chromatographic methods to isolate compounds from S. khasinum and chemical and spectral methods to elucidate their structures., Result: Eight compounds, cleomiscosin A(1), 4-methoxy salicylicaldehyde(2), vanillin(3), isovanillin(4), 4-methoxy salicylic acid(5), isovanillic acid(6), 2,4-dihydroxy-benzoic acid(7) and 4-hydroxy-benzoic acid(8) were isolated from the stem of S. khasianum., Conclusion: Except compound 2, all the compounds were obtained from this plant for the first time.
- Published
- 2000
76. A new triterpenoid from Stelmatocrypton khasianum.
- Author
-
Zhang QY, Zhao YY, Cheng TM, Cui YX, and Liu XH
- Subjects
- Magnetic Resonance Spectroscopy, Models, Chemical, Triterpenes chemistry, Drugs, Chinese Herbal chemistry, Plant Extracts isolation & purification, Triterpenes isolation & purification
- Abstract
A new triterpenoid, 2alpha-,3beta,-,19alpha-trihydroxy-urs-12-ene-24,28-dioic acid (1), along with two known compounds. 3beta-acetoxy-urs-12-ene-11-one (2) and vomifoliol (3), was isolated from stems of Stelmatocryprton khasianum for the first time. Their structures were elucidated on the basis of chemical and spectroscopic methods.
- Published
- 2000
- Full Text
- View/download PDF
77. [Effects of synthetic isoharringtonine on DNA, RNA, ATP, protein and nucleoprotein of transplanted tumor cells in mice].
- Author
-
Liu LS, Xiao XH, Zhang LD, Zheng RL, Li SB, Cui YX, Pan XF, and Li YL
- Subjects
- Animals, Leukemia, Experimental metabolism, Liver Neoplasms, Experimental metabolism, Mice, Neoplasm Transplantation, Sarcoma 180 metabolism, Stereoisomerism, Adenosine Triphosphate metabolism, Alkaloids pharmacology, DNA, Neoplasm metabolism, Harringtonines pharmacology, Neoplasms, Experimental metabolism, Nucleoproteins metabolism, RNA, Neoplasm metabolism
- Published
- 1986
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.